Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

Evaluation of chemiluminescence, toluidine blue and histopathology for detection of high risk oral precancerous lesions: A cross-sectional study.

Ujaoney S, Motwani MB, Degwekar S, Wadhwan V, Zade P, Chaudhary M, Hazarey V, Thakre TP, Mamtani M.

BMC Clin Pathol. 2012 Mar 12;12:6. doi: 10.1186/1472-6890-12-6.

PMID:
22410295
[PubMed]
Free PMC Article
2.

Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.

Epstein JB, Silverman S Jr, Epstein JD, Lonky SA, Bride MA.

Oral Oncol. 2008 Jun;44(6):538-44. Epub 2007 Nov 8. Erratum in: Oral Oncol. 2008 Jun;44(6):615.

PMID:
17996486
[PubMed - indexed for MEDLINE]
3.

Chemiluminescence and Toluidine Blue as Diagnostic Tools for Detecting Early Stages of Oral Cancer: An invivo Study.

Vashisht N, Ravikiran A, Samatha Y, Rao PC, Naik R, Vashisht D.

J Clin Diagn Res. 2014 Apr;8(4):ZC35-8. doi: 10.7860/JCDR/2014/7746.4259. Epub 2014 Apr 15.

PMID:
24959513
[PubMed]
Free PMC Article
4.

Utility of toluidine blue staining and brush biopsy in precancerous and cancerous oral lesions.

Gupta A, Singh M, Ibrahim R, Mehrotra R.

Acta Cytol. 2007 Sep-Oct;51(5):788-94.

PMID:
17910350
[PubMed - indexed for MEDLINE]
5.

Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions.

Mojsa I, Kaczmarzyk T, Zaleska M, Stypulkowska J, Zapala-Pospiech A, Sadecki D.

J Craniofac Surg. 2012 Mar;23(2):e162-4. doi: 10.1097/SCS.0b013e31824cdbea.

PMID:
22446458
[PubMed - indexed for MEDLINE]
6.

The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma.

Epstein JB, Oakley C, Millner A, Emerton S, van der Meij E, Le N.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 May;83(5):537-47.

PMID:
9159812
[PubMed - indexed for MEDLINE]
7.

Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome.

Zhang L, Williams M, Poh CF, Laronde D, Epstein JB, Durham S, Nakamura H, Berean K, Hovan A, Le ND, Hislop G, Priddy R, Hay J, Lam WL, Rosin MP.

Cancer Res. 2005 Sep 1;65(17):8017-21.

PMID:
16140975
[PubMed - indexed for MEDLINE]
Free Article
8.

Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas.

Onofre MA, Sposto MR, Navarro CM.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 May;91(5):535-40.

PMID:
11346731
[PubMed - indexed for MEDLINE]
9.

Assessment of oral mucosa in normal, precancer and cancer using chemiluminescent illumination, toluidine blue supravital staining and oral exfoliative cytology.

Rajmohan M, Rao UK, Joshua E, Rajasekaran ST, Kannan R.

J Oral Maxillofac Pathol. 2012 Sep;16(3):325-9. doi: 10.4103/0973-029X.102476.

PMID:
23248459
[PubMed]
Free PMC Article
10.

Use of methylene blue as a diagnostic aid in early detection of oral cancer and precancerous lesions.

Chen YW, Lin JS, Fong JH, Wang IK, Chou SJ, Wu CH, Lui MT, Chang CS, Kao SY.

Br J Oral Maxillofac Surg. 2007 Oct;45(7):590-1. Epub 2006 Nov 1.

PMID:
17081665
[PubMed - indexed for MEDLINE]
11.

A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions.

Mehrotra R, Singh M, Thomas S, Nair P, Pandya S, Nigam NS, Shukla P.

J Am Dent Assoc. 2010 Feb;141(2):151-6. Erratum in: J Am Dent Assoc. 2010 Apr;141(4):388.

PMID:
20123872
[PubMed - indexed for MEDLINE]
12.

A chemiluminescent light system in combination with toluidine blue to assess suspicious oral lesions-clinical evaluation and review of the literature.

Kämmerer PW, Rahimi-Nedjat RK, Ziebart T, Bemsch A, Walter C, Al-Nawas B, Koch FP.

Clin Oral Investig. 2014 Jun 3. [Epub ahead of print]

PMID:
24888605
[PubMed - as supplied by publisher]
13.

Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer.

Warnakulasuriya KA, Johnson NW.

J Oral Pathol Med. 1996 Mar;25(3):97-103.

PMID:
9148038
[PubMed - indexed for MEDLINE]
14.

Reliability of toluidine blue vital staining in detection of potentially malignant oral lesions--time to reconsider.

Upadhyay J, Rao NN, Upadhyay RB, Agarwal P.

Asian Pac J Cancer Prev. 2011;12(7):1757-60.

PMID:
22126560
[PubMed - indexed for MEDLINE]
Free Article
15.

Toluidine blue staining in the detection of oral precancerous and malignant lesions.

Silverman S Jr, Migliorati C, Barbosa J.

Oral Surg Oral Med Oral Pathol. 1984 Apr;57(4):379-82.

PMID:
6200814
[PubMed - indexed for MEDLINE]
16.

Oral cancer: Premalignant conditions and screening--an update.

Nair DR, Pruthy R, Pawar U, Chaturvedi P.

J Cancer Res Ther. 2012 Jan;8 Suppl 1:S57-66. doi: 10.4103/0973-1482.92217. Review.

PMID:
22322734
[PubMed - indexed for MEDLINE]
17.

Effectiveness of the Microlux/DLTM Chemiluminescence Device in Screening of Potentially Malignant and Malignant Oral Lesions.

Ibrahim SS, Al-Attas SA, Darwish ZE, Amer HA, Hassan MH.

Asian Pac J Cancer Prev. 2014;15(15):6081-6.

PMID:
25124577
[PubMed - in process]
Free Article
18.

Oral cancer: prevention and detection.

Joseph BK.

Med Princ Pract. 2002;11 Suppl 1:32-5.

PMID:
12123114
[PubMed - indexed for MEDLINE]
19.

Application of in vivo stain of methylene blue as a diagnostic aid in the early detection and screening of oral squamous cell carcinoma and precancer lesions.

Chen YW, Lin JS, Wu CH, Lui MT, Kao SY, Fong Y.

J Chin Med Assoc. 2007 Nov;70(11):497-503.

PMID:
18063504
[PubMed - indexed for MEDLINE]
20.

A community-based RCT for oral cancer screening with toluidine blue.

Su WW, Yen AM, Chiu SY, Chen TH.

J Dent Res. 2010 Sep;89(9):933-7. doi: 10.1177/0022034510373763. Epub 2010 Jun 4.

PMID:
20525960
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk